Clinical Trial: A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

U.S., June 18 -- ClinicalTrials.gov registry received information related to the study (NCT07024173) titled 'A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer' on June 09.

Brief Summary: This study is a multicenter, open-label, randomized controlled, Phase 3 clinical trial.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: Locally Advanced Breast Cancer Metastatic Breast Cancer

Intervention: DRUG: HRS-8080 Tablet

HRS-8080 tablet orally administered.

DRUG: Fulvestrant injection

Fulvestrant injection.

DRUG: Exemestane tablets

Exemestane tablets orally administered.

DRUG: Everolimus Tablets

Everolimus tablets orally administered.

Recruitment Status...